Get the Stockscreener App
0.0642
46.50%
-0.0558
After Hours:
.06
-0.0042
-6.54%
Bio Path Holdings Inc stock is traded at $0.0642, with a volume of 23,824.
It is down -46.50% in the last 24 hours and down -46.50% over the past month.
See More
Previous Close:
$0.12
Open:
$0.078925
24h Volume:
23,824
Relative Volume:
29.34
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-16.08M
P/E Ratio:
-0.00186
EPS:
-34.43
Net Cash Flow:
$-11.54M
1W Performance:
-46.50%
1M Performance:
-46.50%
6M Performance:
-86.27%
1Y Performance:
-97.18%
1-Day Range:
$0.0642
$0.0819
1-Week Range:
$0.0642
$0.0819
52-Week Range:
$0.0642
$0.12
Bio Path Holdings Inc Stock (BPTH) Company Profile
Compare BPTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BPTH
Bio Path Holdings Inc
|
0.0642 | 0 | 0 | -16.08M | -11.54M | -34.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Bio Path Holdings Inc Stock (BPTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-11-21 | Initiated | ROTH Capital | Buy |
| Nov-13-17 | Reiterated | H.C. Wainwright | Buy |
| Aug-10-16 | Reiterated | Maxim Group | Buy |
| Apr-18-16 | Initiated | Rodman & Renshaw | Buy |
| Jun-02-14 | Resumed | Maxim Group | Buy |
| May-09-14 | Initiated | Maxim Group | Buy |
View All
Bio Path Holdings Inc Stock (BPTH) Latest News
Is Tevogen Bio Holdings Inc. stock a top pick in earnings seasonForecast Cut & Growth-Oriented Investment Plans - newser.com
Bio-Path Rockets To 4-Month High As Obesity Drug Shows Promise For Diabetes: Retail In Celebration Mode - MSN
Cutaneous T Cell Lymphoma Pipeline Drugs Insights Report 2025: - openPR.com
Cash per share of Bio-Path Holdings, Inc. – OTC:BPTH - TradingView
Comprehensive 2025 Chronic Myeloid Leukemia (CML) Treatment Market Intelligence: Navigate Expansion to 2034 - WhaTech
How Bio Path Holdings Inc. (IBP0) stock valuation compares with sectorJuly 2025 Decliners & Consistent Return Strategy Ideas - newser.com
How supply shortages influence Bio Path Holdings Inc. (IBP0) stockTake Profit & Intraday High Probability Setup Alerts - newser.com
Bio-Path Holdings Provides Clinical and Operational Update - ADVFN
Antisense Oligonucleotides Market Trends Report 2025-2035, Profiles of Antisense Therapeutics, Biogen, Bio-Path, Ionis, ProQR, Sarepta, Sterna Biologicals, Wave Life SciencesResearchAndMarkets.com - The AI Journal
Will Supply Chain Issues Impact DUDigital Global Limiteds PerformancePrice Channel Trading & Free Extraordinary Earning Power - earlytimes.in
Is Bio Path Holdings Inc IBP0 a good long term investmentMorning Star Patterns & Rapid Portfolio Investment - earlytimes.in
Bio-Path readies for key 2025 clinical milestones By Investing.com - Investing.com Nigeria
Gossamer Bio Inc. stock trend outlook and recovery pathJuly 2025 Drop Watch & Intraday High Probability Alerts - newser.com
Why Tevogen Bio Holdings Inc. stock remains a top recommendation2025 Historical Comparison & Weekly Top Gainers Trade List - newser.com
What drives Bio Path Holdings Inc IBP0 stock priceFundamental Strength Indicators & Exceptional Capital Trading - Early Times
What’s the recovery path for long term holders of Bio Techne CorporationMarket Performance Recap & Reliable Breakout Forecasts - newser.com
LeddarTech Holdings Inc. Equity Warrant stock trend outlook and recovery pathJuly 2025 Pullbacks & Daily Volume Surge Trade Alerts - newser.com
What’s the recovery path for long term holders of Fortrea Holdings Inc.2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity - Business Wire
Entera Bio Ltd. stock trend outlook and recovery path2025 Price Action Summary & Weekly High Return Forecasts - newser.com
When Will Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Turn A Profit? - simplywall.st
What’s the recovery path for long term holders of CERo Therapeutics Holdings Inc. Equity Warrant2025 Big Picture & Accurate Entry and Exit Point Alerts - newser.com
MultiSensor AI Holdings Inc. Equity Warrant stock trend outlook and recovery pathNew Guidance & Free Safe Entry Trade Signal Reports - newser.com
Euro Tech Holdings Company Limited stock trend outlook and recovery pathEarnings Miss & AI Forecast Swing Trade Picks - newser.com
What’s the recovery path for long term holders of GoodRx Holdings Inc.2025 Support & Resistance & Growth Focused Investment Plans - newser.com
What’s the recovery path for long term holders of Boundless Bio Inc.Portfolio Value Report & Accurate Buy Signal Notifications - newser.com
Equitable Holdings Inc. stock trend outlook and recovery pathJuly 2025 Patterns & Fast Entry and Exit Trade Plans - newser.com
Passage Bio Inc. stock trend outlook and recovery pathInsider Buying & Fast Gain Stock Trading Tips - newser.com
What’s the recovery path for long term holders of Boot Barn Holdings Inc.Trade Exit Report & Advanced Swing Trade Entry Plans - newser.com
Hayward Holdings Inc. stock trend outlook and recovery path2025 AllTime Highs & Weekly Top Gainers Trade List - newser.com
NYXH stock trend outlook and recovery pathWatch List & Verified Technical Trade Signals - newser.com
Allison Transmission Holdings Inc. stock trend outlook and recovery pathJuly 2025 Levels & Weekly High Conviction Ideas - newser.com
What’s the recovery path for long term holders of MARA Holdings Inc.Market Movers & Low Drawdown Momentum Ideas - newser.com
What’s the recovery path for long term holders of bluebird bio Inc.Earnings Overview Report & Accurate Technical Buy Alerts - newser.com
What’s the recovery path for long term holders of Tevogen Bio Holdings Inc. Equity WarrantJuly 2025 Fed Impact & Verified Momentum Watchlists - Newser
What’s the recovery path for long term holders of Nuvation Bio Inc.2025 Breakouts & Breakdowns & Technical Pattern Based Signals - Newser
Bio Path Holdings Inc Stock (BPTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.84%
0.50%
Cap:
|
Volume (24h):